158 related articles for article (PubMed ID: 22913147)
21. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
[TBL] [Abstract][Full Text] [Related]
22. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
23. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
25. [Relation between hepatocarcinoma and hepatitis C virus infection].
Pichardo-Bahena R; Méndez-Sánchez N
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S36-41. PubMed ID: 12712851
[TBL] [Abstract][Full Text] [Related]
26. Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma.
Ikeda A; Shimizu T; Matsumoto Y; Fujii Y; Eso Y; Inuzuka T; Mizuguchi A; Shimizu K; Hatano E; Uemoto S; Chiba T; Marusawa H
Gastroenterology; 2014 Jan; 146(1):222-32.e35. PubMed ID: 24055508
[TBL] [Abstract][Full Text] [Related]
27. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.
Zhang H; Zhu C; Zhao Y; Li M; Wu L; Yang X; Wan X; Wang A; Zhang MQ; Sang X; Zhao H
Oncotarget; 2015 Dec; 6(41):43770-8. PubMed ID: 26540467
[TBL] [Abstract][Full Text] [Related]
30. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
[TBL] [Abstract][Full Text] [Related]
31. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatics analysis of constructing a HCV-related hepatocellular carcinoma miRNA-mRNA regulation network.
Hao R; Lu H; Guo Y; Liu Q; Wang L; Wang Y; Huang A; Tu Z
Medicine (Baltimore); 2021 Aug; 100(33):e26964. PubMed ID: 34414965
[TBL] [Abstract][Full Text] [Related]
33. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
[TBL] [Abstract][Full Text] [Related]
34. A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.
Zhang DY; Goossens N; Guo J; Tsai MC; Chou HI; Altunkaynak C; Sangiovanni A; Iavarone M; Colombo M; Kobayashi M; Kumada H; Villanueva A; Llovet JM; Hoshida Y; Friedman SL
Gut; 2016 Oct; 65(10):1754-64. PubMed ID: 26045137
[TBL] [Abstract][Full Text] [Related]
35. Differential gene expression profiles of hepatocellular carcinomas associated or not with viral infection.
Bellodi-Privato M; Kubrusly MS; Stefano JT; Soares IC; Wakamatsu A; Oliveira AC; Alves VA; Bacchella T; Machado MC; D'Albuquerque LA
Braz J Med Biol Res; 2009 Dec; 42(12):119-1127. PubMed ID: 19893992
[TBL] [Abstract][Full Text] [Related]
36. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
Mas VR; Fisher RA; Archer KJ; Yanek KC; Williams B; Dumur CI; Maluf DG
Transplantation; 2007 Apr; 83(7):973-81. PubMed ID: 17460570
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.
Wurmbach E; Chen YB; Khitrov G; Zhang W; Roayaie S; Schwartz M; Fiel I; Thung S; Mazzaferro V; Bruix J; Bottinger E; Friedman S; Waxman S; Llovet JM
Hepatology; 2007 Apr; 45(4):938-47. PubMed ID: 17393520
[TBL] [Abstract][Full Text] [Related]
38. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.
Huang XX; McCaughan GW; Shackel NA; Gorrell MD
Liver Int; 2007 Sep; 27(7):960-8. PubMed ID: 17696935
[TBL] [Abstract][Full Text] [Related]
40. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]